ストックスクリーナーアプリを入手
0.7142
3.48%
0.024
アフターアワーズ：
.67
-0.0442
-6.19%
前日終値:
$0.6902
開ける：
$0.801
24時間の取引高:
678.32K
Relative Volume:
0.10
時価総額：
$7.52M
収益：
$6.92M
当期純損益:
$-32.03M
株価収益率:
-0.1318
EPS:
-5.4201
ネットキャッシュフロー:
$-22.13M
1週間 パフォーマンス:
-3.47%
1か月 パフォーマンス:
-25.69%
6か月 パフォーマンス:
-70.61%
1年 パフォーマンス:
+185.57%
1日の値動き範囲:
$0.6951
$0.801
1週間の範囲:
$0.6666
$0.801
52週間の値動き範囲:
$0.1521
$4.78
Beyond Air Inc Stock (XAIR) Company Profile
Compare XAIR vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
0.7142 | 7.27M | 6.92M | -32.03M | -22.13M | -5.4201 |
ABT
Abbott Laboratories
|
102.38 | 178.41B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
329.40 | 125.84B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.06 | 111.25B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.00 | 93.26B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.26 | 46.17B | 6.07B | 1.06B | 1.34B | 1.8063 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-17 | 開始されました | D. Boral Capital | Buy |
| 2024-06-25 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-07-28 | 開始されました | Piper Sandler | Overweight |
| 2023-06-15 | 開始されました | BTIG Research | Buy |
| 2021-04-28 | 開始されました | Truist | Buy |
| 2019-10-22 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Beyond Air Inc (XAIR) 最新ニュース
Beyond Air Expands Commercial Access for LungFit PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO) - Bitget
Beyond Air Names Robert Goodman as New CEO - tipranks.com
Beyond Air's Steven A. Lisi resigns as CEO; Robert Goodman named CEO - tradingview.com
[8-K] Beyond Air, Inc. Reports Material Event - Stock Titan
Beyond Air secures GPO deal expanding hospital access to LungFit - investing.com
Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO) - The Manila Times
Nearly 2,000 more hospitals can buy Beyond Air's tankless nitric oxide system - Stock Titan
Beyond Air CEO Steve Lisi resigns, Robert Goodman appointed successor - MSN
Fed Watch: Will Beyond Air Inc outperform the market in YEAR2026 Growth vs Value & Community Trade Idea Sharing - baoquankhu1.vn
Beyond Air CEO Steve Lisi resigns, Robert Goodman named successor By Investing.com - Investing.com Australia
XAIR Technical Analysis | Trend, Signals & Chart Patterns | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
Beyond Air stock sees CEO change as BTIG maintains Neutral rating - au.investing.com
Beyond Air stock sees CEO change as BTIG maintains Neutral rating By Investing.com - Investing.com South Africa
Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO - Bitget
Beyond Air Names Robert Goodman, Chief Comml Officer, as CEO >XAIR - Moomoo
Beyond Air CEO Steve Lisi resigns, Robert Goodman named successor - Investing.com
Beyond Air swaps CEOs as it pushes wider LungFit PH rollout - Stock Titan
Signal Recap: Is Beyond Air Inc showing insider buyingMarket Risk Report & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Earnings Risk: Will Beyond Air Inc stock benefit from M AWeekly Trade Recap & Low Risk Entry Point Guides - baoquankhu1.vn
Beyond Air appoints Duke Drewell as interim CFO - MSN
Form 8K Beyond Air Inc For: 15 January - Investing.com
XAIR Stock Price, Quote & Chart | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
Beyond Air, Inc. Trade Ideas — GETTEX:48L0 - TradingView
Beyond Air (XAIR) Retains 'Buy' Rating with $10 PT by D. Boral C - gurufocus.com
Beyond Air (XAIR) Sees Promising Phase 1 Trial Results for Cance - GuruFocus
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial - The Manila Times
High-dose nitric oxide shot shows early activity in small cancer trial - Stock Titan
Beyond Air at Life Sciences Forum: Strategic Innovations in Medical Devices - Investing.com Canada
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR) - The Globe and Mail
XAIR: Second-generation nitric oxide system targets global growth and improved hospital adoption - TradingView
Beyond Air to Participate in the 38th Annual Roth Conference in March - The Manila Times
Beyond Air terminates NeuroNOS sale talks with XTL Biopharmaceuticals By Investing.com - Investing.com Canada
Beyond Air terminates NeuroNOS sale talks with XTL Biopharmaceuticals - Investing.com South Africa
XTL Biopharmaceuticals (NASDAQ: XTLB) NeuroNOS deal LOI expires with Beyond Air - Stock Titan
Beyond Air (XAIR) Buy Rating Reaffirmed by D. Boral Capital | XA - GuruFocus
Beyond Air Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. - Bitget
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. - The Manila Times
Beyond Air drops NeuroNOS sale, rethinks neurological and cancer plans - Stock Titan
XTL Biopharmaceuticals Ltd. cancelled the acquisition of 85% stake in NeuroNos Limited from Beyond Air, Inc.. - marketscreener.com
New Highs: Is Beyond Air Inc stock a falling knife or bargain buy2025 Biggest Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Technical Analysis: Can Beyond Air Inc continue delivering strong returns2025 Risk Factors & Verified Short-Term Trading Plans - baoquankhu1.vn
Insider Sell: Will Beyond Air Inc benefit from geopolitical trends2025 Short Interest & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Swing Trade: Is Beyond Air Inc stock a buy or sellWeekly Trading Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Beyond Air Inc (XAIR) Expands Focus on Nitric Oxide Therapies - Finviz
12 Best NASDAQ Penny Stocks to Buy According to Analysts - Insider Monkey
Published on: 2026-03-02 20:03:07 - baoquankhu1.vn
Bull Bear: Can Beyond Air Inc deliver consistent EPS growthJuly 2025 Setups & Stock Portfolio Risk Management - baoquankhu1.vn
XAIR Should I Buy - Intellectia AI
XAIR PE Ratio & Valuation, Is XAIR Overvalued - Intellectia AI
How The Narrative On Beyond Air (XAIR) Is Resetting Around LungFit PH And Delayed Approval - Yahoo Finance
Beyond Air Inc (XAIR) 財務データ
収益
当期純利益
現金流量
EPS
0.67%
0.54%
大文字化:
|
ボリューム (24 時間):